Chen Ruixuan, Pang Mingzhen, Yu Hongxue, Luo Fan, Zhang Xiaodong, Su Licong, Li Yanqin, Zhou Shiyu, Xu Ruqi, Gao Qi, Gan Daojing, Xu Xin, Nie Sheng, Hou Fan Fan
Division of Nephrology, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, China.
State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Clin Kidney J. 2024 Aug 23;17(9):sfae247. doi: 10.1093/ckj/sfae247. eCollection 2024 Sep.
The diagnosis of acute myocardial infarction (AMI) using high-sensitivity cardiac troponin T (hs-cTnT) remains challenging in patients with kidney dysfunction.
In this large, multicenter cohort study, a total of 20 912 adults who underwent coronary angiography were included. Kidney function-specific cut-off values of hs-cTnT were determined to improve the specificity without sacrificing sensitivity, as compared with that using traditional cut-off value (14 ng/L) in the normal kidney function group. The diagnostic accuracy of the novel cut-off values was validated in an independent validation cohort.
In the derivation cohort ( = 12 900), 3247 patients had an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m. Even in the absence of AMI, 50.2% of participants with eGFR <60 mL/min/1.73 m had a hs-cTnT concentration ≥14 ng/L. Using 14 ng/L as the threshold of hs-cTnT for diagnosing AMI led to a significantly reduced specificity and positive predictive value in patients with kidney dysfunction, as compared with that in patients with normal kidney function. The kidney function-specific cut-off values were determined as 14, 18 and 48 ng/L for patients with eGFR >60, 60-30 and <30 mL/min/1.73 m, respectively. Using the novel cut-off values, the specificities for diagnosing AMI in participants with different levels of kidney dysfunction were remarkably improved (from 9.1%-52.7% to 52.8-63.0%), without compromising sensitivity (96.6%-97.9%). Similar improvement of diagnostic accuracy was observed in the validation cohort ( = 8012).
The kidney function-specific cut-off values of hs-cTnT may help clinicians to accurately diagnose AMI in patients with kidney dysfunction and avoid the potential overtreatment in practice.
对于肾功能不全的患者,使用高敏心肌肌钙蛋白T(hs-cTnT)诊断急性心肌梗死(AMI)仍然具有挑战性。
在这项大型多中心队列研究中,共纳入了20912名接受冠状动脉造影的成年人。与在肾功能正常组中使用传统临界值(14 ng/L)相比,确定了hs-cTnT的肾功能特异性临界值,以在不牺牲敏感性的情况下提高特异性。在一个独立的验证队列中验证了新临界值的诊断准确性。
在推导队列(n = 12900)中,3247例患者的估计肾小球滤过率(eGFR)<60 mL/min/1.73 m²。即使在没有AMI的情况下,eGFR<60 mL/min/1.73 m²的参与者中也有50.2%的hs-cTnT浓度≥14 ng/L。与肾功能正常的患者相比,以14 ng/L作为hs-cTnT诊断AMI的阈值会导致肾功能不全患者的特异性和阳性预测值显著降低。对于eGFR>60、60 - 30和<30 mL/min/1.73 m²的患者,肾功能特异性临界值分别确定为14、18和48 ng/L。使用新的临界值,在不同肾功能不全水平的参与者中诊断AMI的特异性显著提高(从9.1% - 52.7%提高到52.8% - 63.0%),而不影响敏感性(96.6% - 97.9%)。在验证队列(n = 8012)中也观察到了类似的诊断准确性提高。
hs-cTnT的肾功能特异性临界值可能有助于临床医生准确诊断肾功能不全患者的AMI,并避免实践中的潜在过度治疗。